QuidelOrtho Corp QDEL
$16.77
▲ +1.21%
(+$0.20)
📅 Earnings This Week
Open
$16.55
Prev Close
$16.57
Day Range
$16.00 – $16.86
52W Range
$9.92 – $35.58
Market Cap
$1.14B
Beta
0.69
EPS (TTM)
$-17.82
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1991-02-01 |
| Shares Out. | 68,190,000 |
| Website | quidelortho.com/ ↗ |
| Phone | 18585521100 |
| Employees | 6,500 |
| Revenue | $619.8M |
| Gross Profit | $263.8M |
| Net Income | -$91.8M |
| Free Cash Flow | -$159.4M |
| Total Assets | $5.63B |
| Total Liabilities | $3.78B |
| Equity | $1.85B |
About QuidelOrtho Corp
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
QuidelOrtho Corp is a publicly traded company under the ticker symbol QDEL on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)